作者
Hans-Peter Deigner, Uwe Haberkorn, Ralf Kinscherf
发表日期
2000/4/1
来源
Expert opinion on investigational drugs
卷号
9
期号
4
页码范围
747-764
出版商
Taylor & Francis
简介
Apoptosis is a prerequisite to model the developing nervous system. However, an increased rate of cell death in the adult nervous system underlies neurodegenerative disease and is a hallmark of multiple sclerosis (MS) Alzheimer’s- (AD), Parkinson- (PD), or Huntington’s disease (HD). Cell surface receptors (e.g., CD95/APO-1/Fas; TNF receptor) and their ligands (CD95-L; TNF) as well as evolutionarily conserved mechanisms involving proteases, mitochondrial factors (e.g., Bcl-2-related proteins, reactive oxygen species, mitochondrial membrane potential, opening of the permeability transition pore) or p53 participate in the modulation and execution of cell death. Effectors comprise oxidative stress, inflammatory processes, calcium toxicity and survival factor deficiency. Therapeutic agents are being developed to interfere with these events, thus conferring the potential to be neuroprotective. In this context, drugs with …
引用总数
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202415131210876455555544771014211
学术搜索中的文章
HP Deigner, U Haberkorn, R Kinscherf - Expert opinion on investigational drugs, 2000